BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 28240261)

  • 1. Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation.
    Bian XL; Chen HZ; Yang PB; Li YP; Zhang FN; Zhang JY; Wang WJ; Zhao WX; Zhang S; Chen QT; Zheng Y; Sun XY; Wang XM; Chien KY; Wu Q
    Nat Commun; 2017 Feb; 8():14420. PubMed ID: 28240261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nur77-activated lncRNA WFDC21P attenuates hepatocarcinogenesis via modulating glycolysis.
    Guan YF; Huang QL; Ai YL; Chen QT; Zhao WX; Wang XM; Wu Q; Chen HZ
    Oncogene; 2020 Mar; 39(11):2408-2423. PubMed ID: 31959898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulation of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase by autophagy in low-glycolytic hepatocellular carcinoma cells.
    Jeon JY; Lee H; Park J; Lee M; Park SW; Kim JS; Lee M; Cho B; Kim K; Choi AM; Kim CK; Yun M
    Biochem Biophys Res Commun; 2015 Jul; 463(3):440-6. PubMed ID: 26036577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways.
    Tang Y; Zhang Y; Wang C; Sun Z; Li L; Cheng S; Zhou W
    Cell Physiol Biochem; 2018; 47(1):344-355. PubMed ID: 29768256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ; Chua MS; Wei W; So SK
    Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SL010110, a lead compound, inhibits gluconeogenesis via SIRT2-p300-mediated PEPCK1 degradation and improves glucose homeostasis in diabetic mice.
    Ren YR; Ye YL; Feng Y; Xu TF; Shen Y; Liu J; Huang SL; Shen JH; Leng Y
    Acta Pharmacol Sin; 2021 Nov; 42(11):1834-1846. PubMed ID: 33574568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase.
    Jiang W; Wang S; Xiao M; Lin Y; Zhou L; Lei Q; Xiong Y; Guan KL; Zhao S
    Mol Cell; 2011 Jul; 43(1):33-44. PubMed ID: 21726808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of ApoA-IV with NR4A1 and NR1D1 Represses G6Pase and PEPCK Transcription: Nuclear Receptor-Mediated Downregulation of Hepatic Gluconeogenesis in Mice and a Human Hepatocyte Cell Line.
    Li X; Xu M; Wang F; Ji Y; DavidsoN WS; Li Z; Tso P
    PLoS One; 2015; 10(11):e0142098. PubMed ID: 26556724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
    Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
    Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forcing ATGL expression in hepatocarcinoma cells imposes glycolytic rewiring through PPAR-α/p300-mediated acetylation of p53.
    Di Leo L; Vegliante R; Ciccarone F; Salvatori I; Scimeca M; Bonanno E; Sagnotta A; Grazi GL; Aquilano K; Ciriolo MR
    Oncogene; 2019 Mar; 38(11):1860-1875. PubMed ID: 30367149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma.
    Liu MX; Jin L; Sun SJ; Liu P; Feng X; Cheng ZL; Liu WR; Guan KL; Shi YH; Yuan HX; Xiong Y
    Oncogene; 2018 Mar; 37(12):1637-1653. PubMed ID: 29335519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression.
    Yang J; Jin X; Yan Y; Shao Y; Pan Y; Roberts LR; Zhang J; Huang H; Jiang J
    Sci Rep; 2017 Mar; 7():43864. PubMed ID: 28262837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha.
    Wang B; Hsu SH; Frankel W; Ghoshal K; Jacob ST
    Hepatology; 2012 Jul; 56(1):186-97. PubMed ID: 22318941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis.
    Liu R; Gou D; Xiang J; Pan X; Gao Q; Zhou P; Liu Y; Hu J; Wang K; Tang N
    Oncogene; 2021 Dec; 40(50):6707-6719. PubMed ID: 34650217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of UBC9 increases the sensitivity of hepatocellular carcinoma to doxorubicin.
    Fang S; Qiu J; Wu Z; Bai T; Guo W
    Oncotarget; 2017 Jul; 8(30):49783-49795. PubMed ID: 28572537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting p300/CBP Attenuates Hepatocellular Carcinoma Progression through Epigenetic Regulation of Metabolism.
    Cai LY; Chen SJ; Xiao SH; Sun QJ; Ding CH; Zheng BN; Zhu XY; Liu SQ; Yang F; Yang YX; Zhou B; Luo C; Zhang X; Xie WF
    Cancer Res; 2021 Feb; 81(4):860-872. PubMed ID: 33361394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Nuclear Orphan Receptor Nur77 Alleviates Palmitate-induced Fat Accumulation by Down-regulating G0S2 in HepG2 Cells.
    Zhao N; Li X; Feng Y; Han J; Feng Z; Li X; Wen Y
    Sci Rep; 2018 Mar; 8(1):4809. PubMed ID: 29556076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methionine adenosyltransferase α2 sumoylation positively regulate Bcl-2 expression in human colon and liver cancer cells.
    Tomasi ML; Ryoo M; Ramani K; Tomasi I; Giordano P; Mato JM; Lu SC
    Oncotarget; 2015 Nov; 6(35):37706-23. PubMed ID: 26416353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Nur77 protein turnover through acetylation and deacetylation induced by p300 and HDAC1.
    Kang SA; Na H; Kang HJ; Kim SH; Lee MH; Lee MO
    Biochem Pharmacol; 2010 Sep; 80(6):867-73. PubMed ID: 20438716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
    Zhao R; Wang N; Huang H; Ma W; Yan Q
    Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.